Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Cohort Study to Evaluate the Effectiveness of Drug Concentrations in Predicting Recapture of Response With Weekly ADAlimumab in Crohn's Disease Subjects With Secondary Loss of Response (PRADA)

NCT02896985 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT02896985
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02896985 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Cohort Study to Evaluate the Effectiveness of Drug Concentrations in Predicting Recapture of Response With Weekly ADAlimumab in Crohn's Disease Subjects With Secondary Loss of Response (PRADA)
Lead sponsor
AbbVie
Phase
Observational
Overall status
Completed
Start date
December 16, 2016
Completion date
March 11, 2020
Enrollment
98 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

crohn's disease